Air Freight and Logistics

Globavend

Globavend released FY2025 Semi-Annual earnings on September 9 (EST), actual revenue USD 13.72 M (forecast USD 8.6 M), actual EPS USD 6.0118 (forecast USD 9.86)

Earnings report released on September 9, 2025 (BJT) with actual revenue of USD 6.862 M and EPS of USD 3.005

Globavend released FY2025 Q2 earnings on September 9 (EST), actual revenue USD 6.862 M, actual EPS USD 3.0059

Globavend Holdings Limited to Raise $15 Million Through IPO

Globavend Holdings Establishes Strategic Partnership with Strawberry Cosmetics

Globavend Holdings Ltd. Announces $15 Million Public Offering

Globavend Holdings Holds Special AGM to Approve Increase in Authorized Capital

Globavend released FY2024 9 Months Earnings on February 12, 2025 (EST), with actual revenue of USD 12.46 M and EPS of USD 15.5442

Globavend released FY2024 Q4 earnings on February 12 (EST), actual revenue USD 4.078 M, actual EPS USD 2.9696

Globavend released FY2024 Annual Earnings on February 12 (EST), actual revenue USD 16.54 M, actual EPS USD 18.3934

Globavend released FY2024 Q3 earnings on February 12, 2025 (EST), actual revenue USD 4.078 M, actual EPS USD 2.9696

Globavend released FY2024 Semi-Annual earnings on September 19 (EST), actual revenue USD 8.385 M, actual EPS USD 12.573

Globavend released FY2024 Q1 earnings on September 19, 2024 (EST) with actual revenue of USD 4.192 M and EPS of USD 6.2865

Globavend released FY2024 Q2 earnings on September 19 (EST), actual revenue USD 4.192 M, actual EPS USD 6.2873

Globavend released FY2022 Q4 earnings on January 30, 2024 (EST), with actual revenue of USD 5.112 M and actual EPS of USD 3.218

Globavend released FY2023 Annual Earnings on January 30 (EST), Actual Revenue: USD 18.59 M, Actual EPS: USD 16.4174

Globavend released FY2023 Q3 earnings on January 30, 2024 (EST), with actual revenue of USD 4.593 M and EPS of USD 4.7739

Globavend released FY2023 9 Months earnings on January 30 (EST), actual revenue USD 13.99 M, actual EPS USD 11.6434

Globavend released FY2022 9 Months earnings on January 30, 2024 (EST) with actual revenue of USD 18.91 M and EPS of USD 9.1282

Globavend released FY2023 Q4 earnings on January 30, 2024 (EST), with actual revenue of USD 4.593 M and EPS of USD 4.7739

Processa Pharmaceuticals

Mega Fortune

Agape ATP

cbdMD

VYNE Therapeutics

Inspirato

Medline Inc.

Beneficient

Andersen

Deutsche Post AG

德國郵政

DSV A/S

康捷國際物流

中通快遞

大和

Radiant物流

盛豐物流

聯合包裹

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap